Combined Assessment of HPV and p16 Optimizes Clinical Decision-Making in Head and Neck Cancer of Unknown Primary.

Jörtsö E, Näsman A, Schliemann I, Zupancic M, Sivars L, Dalianis T, Marklund L, Bark R

Open source

DOI
10.1002/cam4.72291
Published
2026 Sep
Container
Cancer medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72291,
  title = {Combined Assessment of HPV and p16 Optimizes Clinical Decision-Making in Head and Neck Cancer of Unknown Primary.},
  author = {Jörtsö E and Näsman A and Schliemann I and Zupancic M and Sivars L and Dalianis T and Marklund L and Bark R},
  year = {2026},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.72291},
  url = {https://doi.org/10.1002/cam4.72291}
}

RIS

TY  - JOUR
TI  - Combined Assessment of HPV and p16 Optimizes Clinical Decision-Making in Head and Neck Cancer of Unknown Primary.
AU  - Jörtsö E
AU  - Näsman A
AU  - Schliemann I
AU  - Zupancic M
AU  - Sivars L
AU  - Dalianis T
AU  - Marklund L
AU  - Bark R
PY  - 2026
JO  - Cancer medicine
DO  - 10.1002/cam4.72291
UR  - https://doi.org/10.1002/cam4.72291
ER  - 

APA

E, J., A, N., I, S., M, Z., L, S., T, D., L, M., & R, B. (2026). Combined Assessment of HPV and p16 Optimizes Clinical Decision-Making in Head and Neck Cancer of Unknown Primary.. Cancer medicine. https://doi.org/10.1002/cam4.72291

Source records